Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 19, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the Company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
The filing details specific transfers of Ordinary Shares from the GlaxoSmithKline Employee Trust ("the GSK Trust") to participants in the SmithKline Beecham Employee Share Option Plan 1991:
- October 17, 2006: Transfer of 21,821 Ordinary Shares.
- October 18, 2006: Transfer of 117,491 Ordinary Shares.
These transactions were advised to the Company on October 19, 2006.
Management Commentary and Risks
The GSK Trust is identified as a discretionary trust where all current and former employees of GlaxoSmithKline plc and its subsidiaries are potential beneficiaries. The filing notes that three directors—Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop—hold an interest in the shares held within the GSK Trust in the same capacity as other employees. No other risks, contingencies, or unusual items are disclosed in this text.
Investor Verification Points
- Verify the total number of shares transferred (139,312) against the Company's internal records for the SmithKline Beecham Employee Share Option Plan 1991.
- Confirm the continued status of the GSK Trust as a discretionary trust for employee beneficiaries.
- Review the specific holdings of Directors Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop to ensure compliance with disclosure rules regarding their indirect interests.